FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313441615> ?p ?o ?g. }

• W4313441615 abstract "Efavirenz is an anti-HIV drug, and cytochrome P450 46A1 (CYP46A1) is a CNS-specific enzyme that metabolizes cholesterol to 24-hydroxycholesterol (24HC). We have previously shown that allosteric CYP46A1 activation by low-dose efavirenz in a transgenic mouse model of Alzheimer's disease (AD) enhanced both cholesterol elimination and turnover in the brain and improved animal performance in memory tests. Here, we sought to determine whether CYP46A1 could be similarly activated by a low-dose efavirenz in human subjects. METHODS: This pilot study enrolled 5 subjects with early AD. Participants were randomized to placebo (n = 1) or two daily efavirenz doses (50 mg and 200 mg, n = 2 for each) for 20 weeks and evaluated for safety and CYP46A1 target engagement (plasma 24HC levels). A longitudinal mixed model was used to ascertain the statistical significance of target engagement. We also measured 24HC in CSF and conducted a unique stable isotope labeling kinetics (SILK) study with deuterated water to directly measure CYP46A1 activity changes in the brain.In subjects receiving efavirenz, there was a statistically significant within-group increase (P ≤ 0.001) in the levels of plasma 24HC from baseline. The levels of 24HC in the CSF of subjects on the 200-mg dose of efavirenz were also increased. Target engagement was further supported by the labeling kinetics of 24HC by deuterated water in the SILK study. There were no serious adverse effects in any subjects.Our findings suggest efavirenz target engagement in human subjects with early AD. This supports the pursuit of a larger trial for further determination and confirmation of the efavirenz dose that exerts maximal enzyme activation, as well as evaluation of this drug's effects on AD biomarkers and clinical symptomatology.ClinicalTrials.gov, NCT03706885." @default.
• W4313441615 created "2023-01-06" @default.
• W4313441615 creator A5020708775 @default.
• W4313441615 creator A5032502878 @default.
• W4313441615 creator A5037228588 @default.
• W4313441615 creator A5050190797 @default.
• W4313441615 creator A5056542320 @default.
• W4313441615 creator A5058475515 @default.
• W4313441615 creator A5062686238 @default.
• W4313441615 creator A5068146736 @default.
• W4313441615 creator A5070676250 @default.
• W4313441615 creator A5086122346 @default.
• W4313441615 creator A5088881304 @default.
• W4313441615 creator A5088982725 @default.
• W4313441615 creator A5091578997 @default.
• W4313441615 date "2022-12-29" @default.
• W4313441615 modified "2023-09-26" @default.
• W4313441615 title "CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease" @default.
• W4313441615 cites W1480168999 @default.
• W4313441615 cites W1847168837 @default.
• W4313441615 cites W1920999415 @default.
• W4313441615 cites W1975806945 @default.
• W4313441615 cites W1982493902 @default.
• W4313441615 cites W2002793897 @default.
• W4313441615 cites W2003742510 @default.
• W4313441615 cites W2007960303 @default.
• W4313441615 cites W2008854521 @default.
• W4313441615 cites W2013864378 @default.
• W4313441615 cites W2013889250 @default.
• W4313441615 cites W2018952034 @default.
• W4313441615 cites W2037416738 @default.
• W4313441615 cites W2038605859 @default.
• W4313441615 cites W2057365200 @default.
• W4313441615 cites W2058161128 @default.
• W4313441615 cites W2059071540 @default.
• W4313441615 cites W2073741367 @default.
• W4313441615 cites W2078976507 @default.
• W4313441615 cites W2081722421 @default.
• W4313441615 cites W2084011989 @default.
• W4313441615 cites W2088429050 @default.
• W4313441615 cites W2092508662 @default.
• W4313441615 cites W2102736631 @default.
• W4313441615 cites W2105337764 @default.
• W4313441615 cites W2106009748 @default.
• W4313441615 cites W2109417691 @default.
• W4313441615 cites W2121101037 @default.
• W4313441615 cites W2121836743 @default.
• W4313441615 cites W2129577237 @default.
• W4313441615 cites W2134458253 @default.
• W4313441615 cites W2135029574 @default.
• W4313441615 cites W2136250824 @default.
• W4313441615 cites W2148080316 @default.
• W4313441615 cites W2164535648 @default.
• W4313441615 cites W2167311298 @default.
• W4313441615 cites W2170644095 @default.
• W4313441615 cites W2272055653 @default.
• W4313441615 cites W2298887234 @default.
• W4313441615 cites W2468280048 @default.
• W4313441615 cites W2518932391 @default.
• W4313441615 cites W2700577086 @default.
• W4313441615 cites W2810783851 @default.
• W4313441615 cites W2944408171 @default.
• W4313441615 cites W2944738928 @default.
• W4313441615 cites W3016263068 @default.
• W4313441615 cites W3103328760 @default.
• W4313441615 cites W3165690917 @default.
• W4313441615 cites W3179713897 @default.
• W4313441615 cites W3182669460 @default.
• W4313441615 cites W4200032028 @default.
• W4313441615 cites W4281732889 @default.
• W4313441615 cites W4285044179 @default.
• W4313441615 doi "https://doi.org/10.1186/s13195-022-01151-z" @default.
• W4313441615 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36581878" @default.
• W4313441615 hasPublicationYear "2022" @default.
• W4313441615 type Work @default.
• W4313441615 citedByCount "4" @default.
• W4313441615 countsByYear W43134416152023 @default.
• W4313441615 crossrefType "journal-article" @default.
• W4313441615 hasAuthorship W4313441615A5020708775 @default.
• W4313441615 hasAuthorship W4313441615A5032502878 @default.
• W4313441615 hasAuthorship W4313441615A5037228588 @default.
• W4313441615 hasAuthorship W4313441615A5050190797 @default.
• W4313441615 hasAuthorship W4313441615A5056542320 @default.
• W4313441615 hasAuthorship W4313441615A5058475515 @default.
• W4313441615 hasAuthorship W4313441615A5062686238 @default.
• W4313441615 hasAuthorship W4313441615A5068146736 @default.
• W4313441615 hasAuthorship W4313441615A5070676250 @default.
• W4313441615 hasAuthorship W4313441615A5086122346 @default.
• W4313441615 hasAuthorship W4313441615A5088881304 @default.
• W4313441615 hasAuthorship W4313441615A5088982725 @default.
• W4313441615 hasAuthorship W4313441615A5091578997 @default.
• W4313441615 hasBestOaLocation W43134416151 @default.
• W4313441615 hasConcept C112705442 @default.
• W4313441615 hasConcept C126322002 @default.
• W4313441615 hasConcept C134018914 @default.
• W4313441615 hasConcept C142462285 @default.
• W4313441615 hasConcept C142724271 @default.
• W4313441615 hasConcept C185592680 @default.
• W4313441615 hasConcept C197934379 @default.
• W4313441615 hasConcept C203014093 @default.

• next